Clicky

mobile btn
Saturday, April 5th, 2025

Research

CISA issues Infrastructure Dependency Primer resource

Cybersecurity and Infrastructure Security Agency (CISA) personnel said the agency has issued an Infrastructure Dependency Primer (IDP) to aid state, local, tribal, and territorial planners in gaining infrastructure dependency insight. The IDP resource supplements CISA’s recently published... Read More »

Northrop Grumman touts GBSD rocket motor milestone

Northrop Grumman recently attained a Ground Based Strategic Deterrent (GBSD) first-stage solid rocket motor manufacturing milestone by successfully executing the first insulation and case wind processes. “Working closely with the Air Force and nationwide team of industry partners, we continue... Read More »

NSA, National Cryptologic Foundation form partnership

National Security Agency (NSA) recently announced a partnership with the National Cryptologic Foundation to strengthen domestic cybersecurity education and cybersecurity job possibilities. The collaboration is expected to promote a deeper understanding of prior domestic cryptologic successes;... Read More »

DHS inventors earn remote alarm patent

The U.S. Department of Homeland Security (DHS) Science and Technology Directorate (S&T) said two inventors within the National Urban Security Technology Laboratory (NUSTL) have received remote alarm patents. Electronics engineer Norman Chiu and physicist Paul Goldhagen were granted U.S. Patent... Read More »

DARPA: WMD threat sensors tested in police vehicles

In collaboration with the Indianapolis Metropolitan Police Department (IMPD), the Defense Advanced Research Projects Agency’s (DARPA) SIGMA+ program announced Friday it had recently concluded a three-month-long pilot study of sensors intended to support early detection of weapons of mass... Read More »

Novartis expands Pfizer-BioNTech COVID-19 vaccine support

Novartis officials said the company has established an agreement leveraging its manufacturing capacity and capabilities to address the COVID-19 pandemic by expanding Pfizer-BioNTech vaccine support. The agreement targets the fill and finish of more than 50 million doses in 2021 at the Novartis... Read More »